Shareholders Lose Suit Over Glaucoma Drug Trial
A New Jersey federal judge on Monday threw out a proposed shareholder class action claiming Aerie Pharmaceuticals Inc. misled investors about the potential of a new glaucoma treatment, saying the investors...To view the full article, register now.
Already a subscriber? Click here to view full article